Felzartamab(MOR-202) is a human-targeted monoclonal antibody to CD38 for the study of multiple myeloma and advanced antibody-mediated rejection of allogeneic kidney transplants.
CAS Number:
[2197112-39-1]
Target:
CD38
* VAT and and shipping costs not included. Errors and price changes excepted